Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
Cidara will also participate in one-on-one investor meetings during this event. Investors interested in meeting with Cidara at the conference should contact their Guggenheim representative directly.
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference
A live webcast of the fireside chat can be accessed through the Investors & Media section of the Company’s website at https://investors.vaxcyte.com. A replay of the webcast will be available for ...
beautypackaging12h
Estee Lauder Companies and MIT Research Sustainable Biotech Cosmetic Materials
Working with the Langer and Jaklenec Labs, this collaboration will develop ‘solutions to combat the effects of visible light from the sun.’ ...
Vir Biotechnology appoints new Chief Technical Officer
Vir Biotechnology, Inc., a $1.5 billion market cap biotech company, announced a change in its executive team with the upcoming departure of Ann (Aine) M. Hanly, Ph.D., and the appointment of Maninder ...
Japanese automaker Nissan says it plans job and production cuts in the U.S.
TOKYO (AP) — Nissan is slashing production at its U.S. plants and offering buyouts to factory workers there as part of the ...